The company develops skin care products with its proprietary nanotechnological platform based on the development of Bioactive Complex Modeling (NANO-COMPLEXES™) that has the ability to control nano- and pico- quantities of biologically active substances.
BioPAL provides products and methods to measure in vivo organ function and to track compounds-of-interest in in vivo systems. Products developed for neutron activation technology include nanocolloids for labeling, tracking and quantifying cells in in vivo models.
Through its diagnostic program, Biophage is developing a biosensor using an innovative nanotechnology. These nanosensors are based on impedance spectroscopy, an enabling technology that can detect and quantify microbial pathogens in real-time. The unique nanosensors will be built from various proprietary technologies already developed by Biophage (biocapture molecule: phages and antibodies) and by the Biotechnology Research Institute-NRC (signal generation and detection).
The company has a polymer micro-system technology platform comprising core intellectual property in the areas of polymer multilevel micro- and nano-replication, plastic micro-fluidic chip fabrication and photonics integration, to provide unique products for point-of-use analytical applications.
BioSolar, Inc. has developed a breakthrough technology to produce bio-based materials from renewable plant sources. Through the advanced manipulation of bio-based polymers, BioSolar intends to produce robust bio-based components that meet the stringent thermal and durability requirements of current solar cell manufacturing processes.
Blend Therapeutics is a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases. The company is pioneering an integrative way to discover molecular entities with new mechanisms of action purposely designed for our proprietary nanoparticles. By synergistically developing both the molecule and the nanoparticle together they can make medicines more targeted, more effective and more tolerable.
Evolved from more than 15 years research at Sydney's Macquarie University, BluGlass has invented a novel process using Remote Plasma Chemical Vapour Deposition (RPCVD) to grow semiconductor materials such as gallium nitride (GaN), crucial to the production of high efficiency devices including next generation lighting technology Light Emitting Diodes (LEDs) at a fraction of the current cost.
BOC Edwards is a leading supplier to the world's most advanced industries including semiconductor, compound semiconductor, chemical, pharmaceutical, metallurgy, scientific instrumentation and research & development.
The company's core competence is the selective modification of glass by generating metal nanoellipsoids inside the glass material.Boraglas develops and commercializes laser-based nanotechnologies especially for glass material which is applied for the manufacturing of nanotechnology products.
BREC Solutions Limited is one of the leading consultancies in nanotechnology innovation. They offer services in research and development, information tracking, technology scouting, standardisation, and regulation briefings. They are part of the increasing number of stakeholder expert groups in nanotechnology where they represent their clients.
Bridge8 advises small and medium size organisations where creating vision and making connections between organisations and their communities is vital to success. Bridge8 brings specific capabilities in foresight and strategy facilitation and development, and marketing and communications for science and technology.
Bruker is one of the world's leading analytical instrumentation companies. Bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability.